This video reviews controversies in the treatment of early-stage hormone receptor (HR)-positive breast cancer.
In this video, Vered Stearns, MD, of Johns Hopkins School of Medicine in Baltimore, Maryland, reviews controversies in the treatment of early-stage hormone receptor (HR)-positive breast cancer.
Stearns gave a presentation on this topic at the 2017 San Antonio Breast Cancer Symposium (SABCS), held December 5–9 in San Antonio, Texas.
Stay up to date on recent advances in the multidisciplinary approach to cancer.